Dubai: A Saudi research team from Qassim University has discovered an extremely rare genetic disorder, Bethlem Myopathy, for ...

Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential ...

Recently, Chief Justice DY Chandrachud shared the challenges faced by his foster daughters, who are battling a rare ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

A powerful advocate for disability rights, Chloe, now 28, has been co-opted to Muscular Dystrophy UK's Board of Trustees, ...

Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic inflammatory myopathy – – Overall response rate (ORR) of 83% ...

A 58-year-old male patient from Tripura was successfully treated for critical illnesses including septic shock and multi-organ dysfunction syndrome after 32 days at Father Muller Medical College ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial ...

Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital ...

A 58-year-old male patient from Tripura was airlifted to Father Muller Medical College Hospital (FMMCH) after 14 days of intensive care at a hospital in Agartala, where he was treated for multiple ...

Once initiated, Ntrust-2 will enroll patients with systemic sclerosis (scleroderma), idiopathic inflammatory myopathy (myositis), and ANCA-associated vasculitis into parallel cohorts, and NKX019 will ...